Observational Study of Recombinant Factor-VIII-Fc, Eloctate, in Hemophilia Patients with and without Inhibitors

被引：0
|
作者：
Ebbert, Patrick T.
Ragni, Margaret V.
Xavier, Frederico
Malec, Lynn M.
Seaman, Craig D.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3689
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A
    Ebbert, Patrick T.
    Xavier, Frederico
    Malec, Lynn M.
    Seaman, Craig D.
    Ragni, Margaret, V
    THROMBOSIS RESEARCH, 2020, 195 : 51 - 54
  • [2] Clinical Use of Recombinant Factor VIII Fc and Recombinant Factor IX Fc in Patients with Hemophilia A and B
    Wang, Cassandra
    Young, Guy
    BLOOD, 2017, 130
  • [3] Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe
    Mancuso, Maria Elisa
    Castaman, Giancarlo
    Pochopien, Michal
    Aballea, Samuel
    Drzewiecka, Aleksandra
    Hakimi, Zalmai
    Nazir, Jameel
    Fatoye, Francis
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 1068 - 1075
  • [4] Australian comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein (Eloctate®)
    Kershaw, Geoffrey
    Chen, Vivien M.
    Cai, Nancy
    Khoo, Teh-Liane
    HAEMOPHILIA, 2020, 26 (05) : E226 - E229
  • [5] Factor VIII inhibitors in patients with hemophilia A
    Ören, H
    Yaprak, I
    Irken, G
    ACTA HAEMATOLOGICA, 1999, 102 (01) : 42 - 46
  • [6] Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
    Powell, Jerry S.
    Josephson, Neil C.
    Quon, Doris
    Ragni, Margaret V.
    Cheng, Gregory
    Li, Ella
    Jiang, Haiyan
    Li, Lian
    Dumont, Jennifer A.
    Goyal, Jaya
    Zhang, Xin
    Sommer, Jurg
    McCue, Justin
    Barbetti, Margaret
    Luk, Alvin
    Pierce, Glenn F.
    BLOOD, 2012, 119 (13) : 3031 - 3037
  • [7] Surgery-associated factor VIII inhibitors in patients without hemophilia
    Alumkal, J
    Rice, L
    Vempathy, H
    McCarthy, JJ
    Riggs, SA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (05): : 350 - 352
  • [8] Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
    Mahlangu, Johnny
    Powell, Jerry S.
    Ragni, Margaret V.
    Chowdary, Pratima
    Josephson, Neil C.
    Pabinger, Ingrid
    Hanabusa, Hideji
    Gupta, Naresh
    Kulkarni, Roshni
    Fogarty, Patrick
    Perry, David
    Shapiro, Amy
    Pasi, K. John
    Apte, Shashikant
    Nestorov, Ivan
    Jiang, Haiyan
    Li, Shuanglian
    Neelakantan, Srividya
    Cristiano, Lynda M.
    Goyal, Jaya
    Sommer, Jurg M.
    Dumont, Jennifer A.
    Dodd, Nigel
    Nugent, Karen
    Vigliani, Gloria
    Luk, Alvin
    Brennan, Aoife
    Pierce, Glenn F.
    BLOOD, 2014, 123 (03) : 317 - 325
  • [9] Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand
    Alvarez-Roman, Maria-Teresa
    Shapiro, Amy D.
    Ragni, Margaret V.
    Palmborg, Helena
    Bystricka, Linda
    Szamosi, Johan
    Casiano, Sandra
    Chambost, Herve
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (06)
  • [10] Inhibitors of Factor VIII in Black Patients with Hemophilia
    Viel, Kevin R.
    Ameri, Afshin
    Abshire, Thomas C.
    Iyer, Rathi V.
    Watts, Raymond G.
    Lutcher, Charles
    Channell, Cynthia
    Cole, Shelley A.
    Fernstrom, Karl M.
    Nakaya, Shelley
    Kasper, Carol K.
    Thompson, Arthur R.
    Almasy, Laura
    Howard, Tom E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16): : 1618 - 1627
12345